Although no significant differences were found between patients in the BRAF-positive MSS group, BRAF-positive MSI group, and the BRAF-wild-type group regarding GD, the frequency of GD in CRC reached 25% (10/40), which was higher than the frequency of GD in the general population. Here, BRAF is linked to colorectal carcinoma.